Sanofi Faces Antitrust Suit Over Lovenox Contracts
Eisai Inc. has filed an antitrust suit claiming that Sanofi-Aventis' contracts for the anti-coagulant drug Lovenox allow the pharmaceutical giant to maintain an illegal stronghold on the market, leaving just 10...To view the full article, register now.
Already a subscriber? Click here to view full article